11 Long-Term Follow-Up from the OMNIVORE Trial: Response-Adaptive Nivolumab and Ipilimumab in Advanced Renal Cell Carcinoma (NCT03652142)
Michael Serzan, Wanling Xie, Bradley McGregor, David Braun et autres
0 citationsThe Oncologist
Yousef Zakharia
Informations fournies par OpenAlex. Research Africa ne déduit ni nationalité, ni poste, ni coordonnées personnelles.
16Publications signalées
11Citations signalées
9Affiliations récentes
Institutions déclarées
Domaines associés
Renal cell carcinoma treatmentBladder and Urothelial Cancer TreatmentsProstate Cancer Diagnosis and TreatmentUrinary and Genital Oncology StudiesCancer Immunotherapy and Biomarkers
Publications récentes
26 Outcomes of Systemic Therapy in Metastatic Translocation Renal Cell Carcinoma (tRCC): A Mayo Clinic Retrospective Study
Oluwatayo Adeoye, Abiola Bolarinwa, Albert Jang, Alina Maleski et autres
0 citationsThe Oncologist
12 Farnesyl Transferase Inhibitor (FTI) Darlifarnib Combined with Cabozantinib in Renal Cell Carcinoma (RCC): Updated Phase 1a Results from FIT-001
Adanma Ayanambakkam, Yousef Zakharia, Lee S. Rosen, Benjamin Garmezy et autres
0 citationsThe Oncologist
52 FGD1 Splice Variant in Clear Cell Renal Cell Carcinoma is a Novel Biomarker for Inferior Clinical Outcomes and Development of Brain and Bone Metastases
Kendrick Yim, Alyssa Obermayer, Kapil Avasthi, Youngchul Kim et autres
0 citationsThe Oncologist
Clinical Outcomes of HIF-2α inhibition in Von Hippel–Lindau Disease: A Multicenter Real-World Study
Mousab Al Abbas, Jabra Zarka, Alvin C. Silva, Filippo Cingolani et autres
0 citationsThe Oncologist
Enfortumab Vedotin and Pembrolizumab in Cisplatin-Eligible Bladder Cancer
M. Galsky, Begoña P. Valderrama, Marco Maruzzo, Albert Font et autres
10 citationsNew England Journal of Medicine
Structured reasoning failures compromise LLM interpretation of clinical oncology notes
Matthew W. Kenaston, Umair Ayub, Mihir Parmar, Priya Kumar et autres
0 citationsnpj Digital Medicine
Impact of age on the effectiveness of intravesical Bacillus Calmette‑Guérin and gemcitabine/docetaxel in treatment-naïve high-risk non‑muscle‑invasive bladder cancer
Mohamad Abou Chakra, Amanda A. Myers, Kathryn Marchetti, Yousef Zakharia et autres
1 citationTranslational Andrology and Urology
Improving automated prostate cancer risk assessment: An ensemble LLM framework for clinical T-stage inference and NCCN risk stratification.
Umair Ayub, Syed Arsalan Ahmed Naqvi, M. Afzal, Salman Ayub Jajja et autres
0 citationsJournal of Clinical Oncology
Computed tomography ‐derived extracellular volume fraction is associated with high‐grade recurrence in non‐muscle‐invasive bladder cancer treated with intravesical gemcitabine and docetaxel
Mohamad Abou Chakra, Issa Alsamarah, Helen Y. Hougen, Yousef Zakharia et autres
0 citationsBritish Journal of Urology
Hybrid AI framework for automated prostate cancer disease state ascertainment from real-world electronic health records.
Umair Ayub, Syed Arsalan Ahmed Naqvi, Muhammad Uzair Sarfraz, Fouad Nahhat et autres
0 citationsJournal of Clinical Oncology
Neoadjuvant and adjuvant enfortumab vedotin plus pembrolizumab for participants with muscle-invasive bladder cancer who are eligible for cisplatin: Randomized, open-label, phase 3 KEYNOTE-B15 study.
Christopher J. Hoimes, Matthew D. Galsky, Begoña P. Valderrama, Marco Maruzzo et autres
0 citationsJournal of Clinical Oncology
BNTIC News n’est pas le producteur de ces données. Recherche à la demande dans Crossref et Europe PMC, sans clé ; OpenAlex reste optionnel. Aucun service payant requis, aucune réponse conservée. Sources et limites.